Key Highlights
Medicine · Endocrinology
This narrative review examines obesity as a common metabolic complication in patients with classic congenital adrenal hyperplasia (CCAH), a disorder primarily caused by 21-hydroxylase deficiency. The authors detail how long-term supraphysiological glucocorticoid therapy, combined with disease-inherent factors, contributes to obesity through complex, multifactorial mechanisms. For a medical student focused on clinically relevant research, this review provides essential insights into the incidence, influencing factors, and management strategies for obesity in CCAH, directly supporting evidence-based practice in endocrinology and improving long-term patient outcomes.
Novelty: 78%
Rigor: 85%
Significance: 82%
Validity: 88%
Clarity: 90%
Update Your Briefing Preferences
Stay curious. Stay informed —
Science Briefing
Your briefing is personalized based on your selected fields, keywords, and research interests.
